Cutler Group LP Cytom X Therapeutics, Inc. Call Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 Apr 26, 2021	BUY	$6.6 - $9.0 $3,960 - $5,400	600 Added 600.0%	700 $0
Q2 2020 Jul 22, 2020	SELL	$7.4 - $14.64 $77,700 - $153,720	-10,500 Reduced 99.06%	100 $0
Q2 2018 Aug 10, 2018	SELL	$21.38 - $29.68 $2,138 - $2,968	-100 Reduced 0.93%	10,600 $4,000
Q1 2018 May 11, 2018	BUY	$21.76 - $34.22 $232,832 - $366,154	10,700 New	10,700 $28,000

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.